CBT in Adolescents With Type 1 Diabetes
The effectiveness of cognitive behavioural therapy (CBT) for adolescents with type 1 diabetes will be tested. This structured, time-limited, problem-orientated therapy will be used to impact on psychosocial factors influencing diabetic control, with the patient and therapist working together on specific goals to develop adaptive strategies.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Randomised Controlled Trial of Cognitive Behaviour Therapy: Efficacy and Acceptability for Adolescents With Type 1 Diabetes.|
- Well Being Questionnaire, Children’s Health locus of control,
- Diabetes Quality of Life for Youths (modified from DCCT),
- Self Efficacy for Diabetes Scale (modified version,),
- Diabetes Family Behaviour Scale, Diabetes Readiness to Change Questionnaire,
- Modified Health Care Climate Questionnaire (at baseline only).
|Study Start Date:||September 2001|
|Estimated Study Completion Date:||June 2005|
Ninety 11-16 year olds with T1DM (duration >1 year), attending paediatric diabetes outpatient clinics based in 4 centres in South-West England, UK, will be recruited to a randomised controlled trial of one to one sessions of CBT versus non-directive supportive counselling. Participants will attend up to 6 sessions (weekly) with either a CBT therapist or a counsellor, with 2 further sessions at 6 and 12 months. Follow up will continue for 12 months post intervention. HbA1c is the primary outcome measure. Psychological measures will also be measured.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00360061
|Bristol Royal Hospital for Children|
|Bristol, United Kingdom, BS2 8BJ|
|Principal Investigator:||Elizabeth C Crowne, MD||UBHT|
|Study Chair:||Ruth J Allen, PhD||University of Bristol|